EpiVax is hosting its 5th Annual Immunogenicity and Tolerance Seminar. Our event is scheduled for Friday, November 15, at the Hilton Amsterdam in the Netherlands.

The seminar will focus on translational research in the fields of immunogenicity and tolerance, with case studies touching on vaccines and biologics.

Featured keynote speakers are to include:

Dr. Annie De Groot
Professor (Research) and Director, Institute for Immunology and Informatics (iCubed)
CEO/CSO, EpiVax
Setting the Stage: Immunogenicity and Tolerance

Prof. Dr. Andrew Godkin
Institute of Infection and Immunity
School of Medicine, Cardiff University
“Treg Response in Human Tumors”

Dr. Celia Berkers
Professor of Metabolomics, Utrecht University
Unraveling the Mechanism of Proteasomal Peptide Splicing

Dr. Adrian Shepherd
Reader in Computational Biology, Birkbeck, University of London
Assessing the Risk of Alloimmune Responses by Scanning the Human Proteome

Dr. Marieme Dembele
Post-Doc, University of McGill, Montreal, Canada
Tregitopes improve murine asthma by promoting highly suppressible and antigen specific Tregs

Dr. Peter de Haan
CSO and Co-founder, Amarna Therapeutics
TBD

Annieck Diks, M.Sc.
Doctoral Candidate, Leiden University Medical Center
B cell Kinetics Following Vaccination

INTERESTED IN ATTENDING OUR SEMINAR?

* Register here! *
Students = €20 | Non-students = €75

INTERESTED IN SPEAKING AT OUR SEMINAR?
* We have speaking slots available! E-mail info@epivax.com your proposed topic and abstract *

In the meantime, we encourage you to browse through our previous Immunogenicity and Tolerance Seminars: